Ngā hua rapu kaituhi

1

Probiotics in inflammatory bowel disease: is it all gut flora modulation? mā Subrata Ghosh

I whakaputaina 2004

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
2

Review article: mode of action and delivery of 5‐aminosalicylic acid – new evidence mā Pierre Desreumaux, Subrata Ghosh

I whakaputaina 2006

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
3

Looking beyond symptom relief: evolution of mucosal healing in inflammatory bowel disease mā Marietta Iacucci, Subrata Ghosh

I whakaputaina 2011

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
4

Intra-articular bupivacaine: potentially chondrotoxic? mā Stephen Webb, Subrata Ghosh

I whakaputaina 2009

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Editorial

Tiaki ki tētahi rārangi

I tiakina i:
5

Review: Anti-adhesion molecule therapy for inflammatory bowel disease mā Subrata Ghosh, Remo Panaccione

I whakaputaina 2010

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
6

Prevention of biliary stent occlusion using cyclical antibiotics and ursodeoxycholic acid. mā Subrata Ghosh, K R Palmer

I whakaputaina 1994

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
7

Mesalazine in Inflammatory Bowel Disease: A Trendy Topic Once Again? mā Marietta Iacucci, Shanika de Silva, Subrata Ghosh

I whakaputaina 2009

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
8

Review article: medication non‐adherence in ulcerative colitis – strategies to improve adherence with mesalazine and other maintenance therapies mā A. B. Hawthorne, Greg Rubin, Subrata Ghosh

I whakaputaina 2008

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
9

Polyunsaturated fatty acids and inflammation mā Rachel Marion‐Letellier, Guillaume Savoye, Subrata Ghosh

I whakaputaina 2015

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
10

IBD: In Food We Trust mā Rachel Marion‐Letellier, Guillaume Savoye, Subrata Ghosh

I whakaputaina 2016

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
11

Blockade of IL-23: What is in the Pipeline? mā Tommaso Lorenzo Parigi, Marietta Iacucci, Subrata Ghosh

I whakaputaina 2021

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
12

Review article: visceral hypersensitivity in irritable bowel syndrome: molecular mechanisms and therapeutic agents mā Ayesha Akbar, Julian R.F. Walters, Subrata Ghosh

I whakaputaina 2009

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
13

Live visualizations of single isolated tubulin protein self-assembly via tunneling current: effect of electromagnetic pumping during spontaneous growth of microtubule mā Satyajit Sahu, Subrata Ghosh, Daisuke Fujita, Anirban Bandyopadhyay

I whakaputaina 2014

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
14

How bad are the symptoms and bowel dysfunction of patients with the irritable bowel syndrome? A prospective, controlled study with emphasis on stool form. mā K W Heaton, Subrata Ghosh, F E Braddon

I whakaputaina 1991

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
15

Optimizing clinical use of mesalazine (5-aminosalicylic acid) in inflammatory bowel disease mā Chadwick Williams, Remo Panaccione, Subrata Ghosh, Kevin P. Rioux

I whakaputaina 2011

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
16

The Role of Vitamin D in Inflammatory Bowel Disease: Mechanism to Management mā Jane Fletcher, Sheldon C. Cooper, Subrata Ghosh, Martin Hewison

I whakaputaina 2019

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
17

Inflammatory Bowel Diseases and Food Additives: To Add Fuel on the Flames! mā Rachel Marion‐Letellier, Asma Amamou, Guillaume Savoye, Subrata Ghosh

I whakaputaina 2019

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
18

Ustekinumab for the treatment of Crohn’s disease: can it find its niche? mā Ebby George Simon, Subrata Ghosh, Marietta Iacucci, Gordon W. Moran

I whakaputaina 2015

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
19

Preoperative use of anti-tumor necrosis factor therapy in Crohn's disease: promises and pitfalls mā Paulo Gustavo Kotze, Subrata Ghosh, Willem A. Bemelman, Remo Panaccione

I whakaputaina 2017

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
20

Induction of Vasculogenic Mimicry Overrides VEGF-A Silencing and Enriches Stem-like Cancer Cells in Melanoma mā Caroline I. Schnegg, Moon Hee Yang, Subrata Ghosh, Mei‐Yu Hsu

I whakaputaina 2015

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:

Ngā hua rapu - Subrata Ghosh

Probiotics in inflammatory bowel disease: is it all gut flora modulation? mā Subrata Ghosh

Review article: mode of action and delivery of 5‐aminosalicylic acid – new evidence mā Pierre Desreumaux, Subrata Ghosh

Looking beyond symptom relief: evolution of mucosal healing in inflammatory bowel disease mā Marietta Iacucci, Subrata Ghosh

Intra-articular bupivacaine: potentially chondrotoxic? mā Stephen Webb, Subrata Ghosh

Review: Anti-adhesion molecule therapy for inflammatory bowel disease mā Subrata Ghosh, Remo Panaccione

Prevention of biliary stent occlusion using cyclical antibiotics and ursodeoxycholic acid. mā Subrata Ghosh, K R Palmer

Mesalazine in Inflammatory Bowel Disease: A Trendy Topic Once Again? mā Marietta Iacucci, Shanika de Silva, Subrata Ghosh

Review article: medication non‐adherence in ulcerative colitis – strategies to improve adherence with mesalazine and other maintenance therapies mā A. B. Hawthorne, Greg Rubin, Subrata Ghosh

Polyunsaturated fatty acids and inflammation mā Rachel Marion‐Letellier, Guillaume Savoye, Subrata Ghosh

IBD: In Food We Trust mā Rachel Marion‐Letellier, Guillaume Savoye, Subrata Ghosh

Blockade of IL-23: What is in the Pipeline? mā Tommaso Lorenzo Parigi, Marietta Iacucci, Subrata Ghosh

Review article: visceral hypersensitivity in irritable bowel syndrome: molecular mechanisms and therapeutic agents mā Ayesha Akbar, Julian R.F. Walters, Subrata Ghosh

Live visualizations of single isolated tubulin protein self-assembly via tunneling current: effect of electromagnetic pumping during spontaneous growth of microtubule mā Satyajit Sahu, Subrata Ghosh, Daisuke Fujita, Anirban Bandyopadhyay

How bad are the symptoms and bowel dysfunction of patients with the irritable bowel syndrome? A prospective, controlled study with emphasis on stool form. mā K W Heaton, Subrata Ghosh, F E Braddon

Optimizing clinical use of mesalazine (5-aminosalicylic acid) in inflammatory bowel disease mā Chadwick Williams, Remo Panaccione, Subrata Ghosh, Kevin P. Rioux

The Role of Vitamin D in Inflammatory Bowel Disease: Mechanism to Management mā Jane Fletcher, Sheldon C. Cooper, Subrata Ghosh, Martin Hewison

Inflammatory Bowel Diseases and Food Additives: To Add Fuel on the Flames! mā Rachel Marion‐Letellier, Asma Amamou, Guillaume Savoye, Subrata Ghosh

Ustekinumab for the treatment of Crohn’s disease: can it find its niche? mā Ebby George Simon, Subrata Ghosh, Marietta Iacucci, Gordon W. Moran

Preoperative use of anti-tumor necrosis factor therapy in Crohn's disease: promises and pitfalls mā Paulo Gustavo Kotze, Subrata Ghosh, Willem A. Bemelman, Remo Panaccione

Induction of Vasculogenic Mimicry Overrides VEGF-A Silencing and Enriches Stem-like Cancer Cells in Melanoma mā Caroline I. Schnegg, Moon Hee Yang, Subrata Ghosh, Mei‐Yu Hsu

Ngā utauta rapu:

Ngā marau whai pānga